2023
Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
Ellingson M, Sheikha H, Nyhan K, Oliveira C, Niccolai L. Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review. Human Vaccines & Immunotherapeutics 2023, 19: 2239085. PMID: 37529935, PMCID: PMC10399474, DOI: 10.1080/21645515.2023.2239085.Peer-Reviewed Original ResearchConceptsVaccine effectivenessSystematic reviewHuman Papillomavirus Vaccine EffectivenessVaccine-type HPV infectionYounger ageHigh vaccine effectivenessHuman papillomavirus vaccineVaccine effectiveness studiesYounger age groupsAdolescents ages 15Adolescents ages 9HPV infectionHPV vaccineVaccine initiationPapillomavirus vaccineTime vaccinationAnogenital wartsCervical abnormalitiesCervical cancerDisease outcomeAge groupsOlder ageEffectiveness studiesAge 15Age
2020
Trends in Anogenital Wart Diagnoses in Connecticut, 2013-2017
Yakely AE, Niccolai LM, Oliveira CR. Trends in Anogenital Wart Diagnoses in Connecticut, 2013-2017. JAMA Network Open 2020, 3: e1920168. PMID: 32003814, PMCID: PMC7042856, DOI: 10.1001/jamanetworkopen.2019.20168.Peer-Reviewed Original Research
2019
Human papillomavirus vaccination and anogenital warts
Yakely AE, Avni-Singer L, Oliveira CR, Niccolai LM. Human papillomavirus vaccination and anogenital warts. Sexually Transmitted Diseases 2019, Publish Ahead of Print: &na;. PMID: 30461595, PMCID: PMC6640846, DOI: 10.1097/olq.0000000000000948.Peer-Reviewed Original ResearchConceptsAnogenital wartsAge 25 yearsHPV vaccineEffectiveness studiesHPV vaccine impactHuman papillomavirus vaccinationPre-vaccine eraMale vaccinationPapillomavirus vaccinationVaccination historyVaccine impactVaccine introductionFemale vaccinationEmbase databasesVaccination programEligible studiesExclusion criteriaLower riskVaccineVaccinationWartsPrevention potentialReal-world benefitsFemalesUnited States